FDA Warns Of More Eye Infections Related To Recalled Dye

Law360, New York (April 20, 2012, 3:33 PM EDT) -- The U.S. Food and Drug Administration said Friday that more eye surgery patients had reported infections after receiving a dye supplied by a Florida laboratory, even though the lab recalled the product more than a month ago.

Franck's Labs Inc. issued a recall for all lots of Brilliant Blue G on March 9, after patients treated with the product suffered fungal eye infections. It sent a letter to doctors who received the dye, and the FDA followed up with a warning statement of its own on...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.